SeQuent to acquire 51% of Indo Phyto

0
1147

SeQuent Scientific has announced that it will acquire a controlling stake in Indo Phyto Chemicals (IPC), a New Delhi-based pharmaceutical company that focuses on female healthcare.

Chemical_structure,_vitamin_DIPC has a portfolio of steroids and hormonal active pharmaceutical ingredients (APIs) along with a manufacturing base in Uttarakhand. The company has capabilities in fermentation and chemical synthesis, giving it the ability to produce APIs from the basic starting materials that are extracted from plants. IPC currently produces 14 APIs and has 20 more under development.

You must be a subscriber to read this content, or you can register for free to enjoy the current issue.

你可以订阅去解锁所有内容。你也可以免费注册去浏览最新一期的内容。